Cargando…

Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth

Alpha-amylase is widely exploited as a drug target for preventing postprandial hyperglycemia in diabetes and other metabolic diseases. Inhibition of this enzyme by plant-derived pregnanes is not fully understood. Herein, we used in vitro, in silico, and in vivo studies to provide further insights in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogunyemi, Oludare M., Gyebi, Gideon A., Saheed, Afolabi, Paul, Jesse, Nwaneri-Chidozie, Victoria, Olorundare, Olufunke, Adebayo, Joseph, Koketsu, Mamoru, Aljarba, Nada, Alkahtani, Saad, Batiha, Gaber El-Saber, Olaiya, Charles O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399641/
https://www.ncbi.nlm.nih.gov/pubmed/36032689
http://dx.doi.org/10.3389/fmolb.2022.866719
_version_ 1784772570900332544
author Ogunyemi, Oludare M.
Gyebi, Gideon A.
Saheed, Afolabi
Paul, Jesse
Nwaneri-Chidozie, Victoria
Olorundare, Olufunke
Adebayo, Joseph
Koketsu, Mamoru
Aljarba, Nada
Alkahtani, Saad
Batiha, Gaber El-Saber
Olaiya, Charles O.
author_facet Ogunyemi, Oludare M.
Gyebi, Gideon A.
Saheed, Afolabi
Paul, Jesse
Nwaneri-Chidozie, Victoria
Olorundare, Olufunke
Adebayo, Joseph
Koketsu, Mamoru
Aljarba, Nada
Alkahtani, Saad
Batiha, Gaber El-Saber
Olaiya, Charles O.
author_sort Ogunyemi, Oludare M.
collection PubMed
description Alpha-amylase is widely exploited as a drug target for preventing postprandial hyperglycemia in diabetes and other metabolic diseases. Inhibition of this enzyme by plant-derived pregnanes is not fully understood. Herein, we used in vitro, in silico, and in vivo studies to provide further insights into the alpha-amylase inhibitory potential of selected pregnane-rich chromatographic fractions and four steroidal pregnane phytochemicals (SPPs), viz: marsectohexol (P1), 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→14)-β-D-oleandropyranosyl]-11,12-di-O-tigloyl-17β-marsdenin (P2), 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl]-17β-marsdenin (P3), and 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-canaropyranosyl]-17β-marsdenin (P4) derived from Gongronema latifolium Benth. The results revealed that the SPPs source pregnane-rich chromatographic fractions and the SPPs (P1–P4) exhibited inhibitory potential against porcine pancreatic alpha-amylase in vitro. Compounds P1 and P2 with IC(50) values 10.01 and 12.10 µM, respectively, showed greater inhibitory potential than the reference acarbose (IC(50) = 13.47 µM). Molecular docking analysis suggests that the SPPs had a strong binding affinity to porcine pancreatic alpha-amylase (PPA), human pancreatic alpha-amylase (HPA), and human salivary alpha-amylase (HSA), interacting with the key active site residues through an array of hydrophobic interactions and hydrogen bonds. The strong interactions of the SPPs with Glu233 and Asp300 residues may disrupt their roles in the acid-base catalytic mechanism and proper orientation of the polymeric substrates, respectively. The interactions with human pancreatic amylase were maintained in a dynamic environment as indicated by the root mean square deviation, radius of gyration, surface accessible surface area, and number of hydrogen bonds computed from the trajectories obtained from a 100-ns molecular dynamics simulation. Key loop regions of HPA that contribute to substrate binding exhibited flexibility and interaction potential toward the compounds as indicated by the root mean square fluctuation. Furthermore, P1 significantly reduced blood glucose levels and area under the curve in albino rats which were orally challenged with starch. Therefore, Gongronema latifolium and its constituent SPPs may be exploited as inhibitors of pancreatic alpha-amylase as an oral policy for impeding postprandial blood glucose rise.
format Online
Article
Text
id pubmed-9399641
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93996412022-08-25 Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth Ogunyemi, Oludare M. Gyebi, Gideon A. Saheed, Afolabi Paul, Jesse Nwaneri-Chidozie, Victoria Olorundare, Olufunke Adebayo, Joseph Koketsu, Mamoru Aljarba, Nada Alkahtani, Saad Batiha, Gaber El-Saber Olaiya, Charles O. Front Mol Biosci Molecular Biosciences Alpha-amylase is widely exploited as a drug target for preventing postprandial hyperglycemia in diabetes and other metabolic diseases. Inhibition of this enzyme by plant-derived pregnanes is not fully understood. Herein, we used in vitro, in silico, and in vivo studies to provide further insights into the alpha-amylase inhibitory potential of selected pregnane-rich chromatographic fractions and four steroidal pregnane phytochemicals (SPPs), viz: marsectohexol (P1), 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→14)-β-D-oleandropyranosyl]-11,12-di-O-tigloyl-17β-marsdenin (P2), 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl]-17β-marsdenin (P3), and 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-canaropyranosyl]-17β-marsdenin (P4) derived from Gongronema latifolium Benth. The results revealed that the SPPs source pregnane-rich chromatographic fractions and the SPPs (P1–P4) exhibited inhibitory potential against porcine pancreatic alpha-amylase in vitro. Compounds P1 and P2 with IC(50) values 10.01 and 12.10 µM, respectively, showed greater inhibitory potential than the reference acarbose (IC(50) = 13.47 µM). Molecular docking analysis suggests that the SPPs had a strong binding affinity to porcine pancreatic alpha-amylase (PPA), human pancreatic alpha-amylase (HPA), and human salivary alpha-amylase (HSA), interacting with the key active site residues through an array of hydrophobic interactions and hydrogen bonds. The strong interactions of the SPPs with Glu233 and Asp300 residues may disrupt their roles in the acid-base catalytic mechanism and proper orientation of the polymeric substrates, respectively. The interactions with human pancreatic amylase were maintained in a dynamic environment as indicated by the root mean square deviation, radius of gyration, surface accessible surface area, and number of hydrogen bonds computed from the trajectories obtained from a 100-ns molecular dynamics simulation. Key loop regions of HPA that contribute to substrate binding exhibited flexibility and interaction potential toward the compounds as indicated by the root mean square fluctuation. Furthermore, P1 significantly reduced blood glucose levels and area under the curve in albino rats which were orally challenged with starch. Therefore, Gongronema latifolium and its constituent SPPs may be exploited as inhibitors of pancreatic alpha-amylase as an oral policy for impeding postprandial blood glucose rise. Frontiers Media S.A. 2022-08-10 /pmc/articles/PMC9399641/ /pubmed/36032689 http://dx.doi.org/10.3389/fmolb.2022.866719 Text en Copyright © 2022 Ogunyemi, Gyebi, Saheed, Paul, Nwaneri-Chidozie, Olorundare, Adebayo, Koketsu, Aljarba, Alkahtani, Batiha and Olaiya. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Ogunyemi, Oludare M.
Gyebi, Gideon A.
Saheed, Afolabi
Paul, Jesse
Nwaneri-Chidozie, Victoria
Olorundare, Olufunke
Adebayo, Joseph
Koketsu, Mamoru
Aljarba, Nada
Alkahtani, Saad
Batiha, Gaber El-Saber
Olaiya, Charles O.
Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth
title Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth
title_full Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth
title_fullStr Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth
title_full_unstemmed Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth
title_short Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from Gongronema latifolium Benth
title_sort inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived from gongronema latifolium benth
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399641/
https://www.ncbi.nlm.nih.gov/pubmed/36032689
http://dx.doi.org/10.3389/fmolb.2022.866719
work_keys_str_mv AT ogunyemioludarem inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT gyebigideona inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT saheedafolabi inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT pauljesse inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT nwanerichidozievictoria inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT olorundareolufunke inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT adebayojoseph inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT koketsumamoru inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT aljarbanada inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT alkahtanisaad inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT batihagaberelsaber inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth
AT olaiyacharleso inhibitionmechanismofalphaamylaseadiabetestargetbyasteroidalpregnaneandpregnaneglycosidesderivedfromgongronemalatifoliumbenth